ongoing

VERDICT-2 is a device verification study which will examine examine the accuracy of the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model: CVSM-1A) in an ambulatory context with healthy participants.

The objective is to determine the accuracy of continuous noninvasive vital signs metrics including respiration, pulse rate, oxyhemoglobin saturation (SpO2), core temperature, heart rate, and continuous non-invasive blood pressure (cNIBP) against standard comparator devices guided by consensus standards.

Study Type

Device

Study Design

Verification

NO. of Countries

1

NO. of Sites

1

NO. of Participants

35

Study Period

2023

Sponsor

PHRI

Cloud Diagnostics Canada ULC

Back To Top